Gray Zone Lymphoma: Clinical Trials

3 trials for Gray Zone Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Active not recruiting 1

Follow Gray Zone Lymphoma: new trials by email Literature Review of Gray Zone Lymphoma trials Research Report on Gray Zone Lymphoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
ATLCAR.CD30.CCR4 cells, ALTCAR.CD30 cells, Bendamustine - Lymphoma, Immune System Diseases
Phase 1Active not recruitingUNC Lineberger Comprehensive Cancer Center432018-10-292026-06-12
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
Bendamustine, Cyclophosphamide - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia
Phase 1CompletedUniversity of Arizona502016-11-292025-11-10
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma
CPX-351 - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 1CompletedChildren's Hospital Medical Center, Cincinnati272013-09-012020-11-09

Narrower conditions

Lymphoma (3)  ·  Burkitt Lymphoma (2)  ·  Hodgkin Disease (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)

Broader conditions

Hemic and Lymphatic Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  DNA Virus Infections (2)  ·  Epstein-Barr Virus Infections (2)  ·  Hematologic Diseases (2)  ·  Herpesviridae Infections (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Infections (2)  ·  Leukemia, Lymphoid (2)  ·  Leukemia, Myeloid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma, B-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoma, T-Cell (2)

Interventions

Bendamustine Hydrochloride (2)  ·  CPX-351 (1)  ·  Cyclophosphamide (1)  ·  fludarabine (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  University of Arizona (1)

Countries

United States (3)

Top investigators

Emmanuel Katsanis, MD (1)  ·  John Perentesis, MD (1)  ·  Natalie Grover, MD (1)

Results publications

PMID 29908231, PMID 32582591, PMID 35460929, PMID 35847727, PMID 40270968

NIH funding

R01CA247497 (1)